- Home
- GH vs CHX Comparison
GH vs CHX Comparison
Compare GH & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- CHX
- Stock Information
- Founded
- GH 2011
- CHX 1882
- Country
- GH United States
- CHX United States
- Employees
- GH N/A
- CHX N/A
- Industry
- GH Medical Specialities
- CHX Industrial Machinery/Components
- Sector
- GH Health Care
- CHX Industrials
- Exchange
- GH Nasdaq
- CHX Nasdaq
- Market Cap
- GH 5.5B
- CHX 4.8B
- IPO Year
- GH 2018
- CHX N/A
- Fundamental
- Price
- GH $41.72
- CHX $25.10
- Analyst Decision
- GH Strong Buy
- CHX Strong Buy
- Analyst Count
- GH 21
- CHX 3
- Target Price
- GH $52.81
- CHX $37.67
- AVG Volume (30 Days)
- GH 2.7M
- CHX 3.9M
- Earning Date
- GH 04-30-2025
- CHX 04-29-2025
- Dividend Yield
- GH N/A
- CHX 1.51%
- EPS Growth
- GH N/A
- CHX N/A
- EPS
- GH N/A
- CHX 1.51
- Revenue
- GH $773,996,000.00
- CHX $3,576,306,000.00
- Revenue This Year
- GH $19.53
- CHX $5.23
- Revenue Next Year
- GH $21.92
- CHX $2.20
- P/E Ratio
- GH N/A
- CHX $16.68
- Revenue Growth
- GH 28.20
- CHX N/A
- 52 Week Low
- GH $18.01
- CHX $21.92
- 52 Week High
- GH $52.92
- CHX $35.94
- Technical
- Relative Strength Index (RSI)
- GH 43.79
- CHX 47.61
- Support Level
- GH $38.86
- CHX $24.09
- Resistance Level
- GH $52.92
- CHX $24.95
- Average True Range (ATR)
- GH 2.91
- CHX 0.74
- MACD
- GH -0.74
- CHX 0.19
- Stochastic Oscillator
- GH 20.34
- CHX 72.71
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.